Workflow
鱼油EPA
icon
Search documents
全球鱼油EPA和DHA市场前20强生产商排名及市场占有率
QYResearch· 2025-07-16 09:00
鱼油是从富含脂肪的鱼类中提取的一种油脂。它富含二十碳五烯酸 (EPA) 、二十二碳六烯酸 (DHA) 和多种 N-3 多不饱和脂肪酸 (N-3PUFA) ,这些都是人体必需的不饱和脂肪酸。 EPA 可以清理血管垃圾,软化血管,提高免疫力,被称为"血管清道夫"; DHA 常用于孕妇和婴幼儿。服用 DHA 可以促进大脑的正常生长发育,从而起到所谓的健脑益智作用,俗称"脑黄金"。 据 QYResearch 调研团队最新报告"全球鱼油 EPA 和 DHA 市场报告 2025-2031 "显示,预计 2031 年全球鱼油 EPA 和 DHA 市场规 模将达到 20.2 亿美元,未来几年年复合增长率 CAGR 为 3.4% 。 鱼油 EPA 和 DHA ,全球市场总体规模 全球 鱼油 EPA 和 DHA 市场前 20 强生产商排名及市场占有率(基于 2 02 4 年调研数据;目前最新数据以本公司最新调研数据为 准) 根据 QYResearch 头部企业研究中心调研,全球范围内鱼油 EPA 和 DHA 生产商主要包括 KD Pharma 、 Croda 、 BASF 、禹王制 药、 GC Rieber VivoMega 、 ...
海洋生物医药概念股表现活跃 诚意药业等涨停
Zhong Zheng Wang· 2025-07-02 06:05
Group 1 - The A-share market saw active performance in marine biopharmaceutical concept stocks, with companies like Chengyi Pharmaceutical, Haiwang Biological, and Dongfang Ocean hitting the daily limit up [1] - The Central Financial Committee emphasized the promotion of a unified national market and the high-quality development of the marine economy [1] - Chengyi Pharmaceutical, as the first listed company in Zhejiang focusing on marine biopharmaceuticals, has a revenue share of nearly 70% from this sector [1] Group 2 - Chengyi Pharmaceutical is leveraging its core businesses of glucosamine and fish oil to establish a strong presence in the marine biopharmaceutical field [1] - The company's key product, hydrochloride glucosamine, is derived from chitin sourced from crab and shrimp shells, offering unique advantages such as being all-natural and additive-free [1] - Chengyi Pharmaceutical has developed a full-chain integration advantage in glucosamine products, from raw material extraction to production [1] Group 3 - Dongfang Ocean is also gaining market attention, focusing on marine seed breeding, aquatic product processing, and biotechnology [2] - The company has established a leading position in sea cucumber farming and fish seed breeding, collaborating with institutions like the Chinese Academy of Sciences and Ocean University of China [2] - Dongfang Ocean is advancing its health industry development by establishing platforms for immune technology, mass spectrometry, molecular technology, and third-party medical testing laboratories [2]